Biotech Acquisition Co - Class A logo

BIOT

Biotech Acquisition Co - Class A

$9.89

Earnings Summary

Revenue
$0Mn
Net Profits
$4.68Mn
Net Profit Margins
+Inf%

Highlights

Revenue:

Biotech Acquisition Co - Class A’s revenue jumped NaN% since last year same period to $0Mn in the Q1 2022. On a quarterly growth basis, Biotech Acquisition Co - Class A has generated NaN% jump in its revenue since last 3-months.

Net Profits:

Biotech Acquisition Co - Class A’s net profit jumped 83.67% since last year same period to $4.68Mn in the Q1 2022. On a quarterly growth basis, Biotech Acquisition Co - Class A has generated 164.2% jump in its net profits since last 3-months.

Net Profit Margins:

Biotech Acquisition Co - Class A’s net profit margin jumped NaN% since last year same period to +Inf% in the Q1 2022. On a quarterly growth basis, Biotech Acquisition Co - Class A has generated NaN% jump in its net profit margins since last 3-months.

Key Ratios

Key ratios of the Biotech Acquisition Co - Class A post its Q1 2022 earnings

Earning Per Share (EPS)
0.16
Return on Assets (ROA)
-0.01
Return on Equity (ROE)
0
Dividend Per Share (DPS)
0

Highlights

Earning Per Share (EPS):

Biotech Acquisition Co - Class A’s earning per share (EPS) jumped 83.63% since last year same period to 0.16 in the Q1 2022. This indicates that the Biotech Acquisition Co - Class A has generated 83.63% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Biotech Acquisition Co - Class A’s return on assets (ROA) stands at -0.01.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Biotech Acquisition Co - Class A’s return on equity (ROE) stands at 0.

Dividend Per Share (DPS):

Biotech Acquisition Co - Class A declared 0 dividend per share during the earnings announcement for Q1 2022.

Company Information

Organisation
Biotech Acquisition Co - Class A
Employees
4